These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26521850)

  • 21. Phase transitions of antibiotic clarithromycin forms I, IV and new form VII crystals.
    Ito M; Shiba R; Watanabe M; Iwao Y; Itai S; Noguchi S
    Int J Pharm; 2018 Aug; 547(1-2):258-264. PubMed ID: 29864514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase Transitions Involving Channel Hydrates of a New Pharmaceutical Compound.
    Kuang S; Shah HS; Zhao B
    Pharm Res; 2024 Jul; 41(7):1533-1541. PubMed ID: 38872035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical characterization of anhydrous and hydrous forms of the hydrochloride salt of BVT.5182 a novel 5-HT(6) receptor antagonist.
    Hugerth A; Brisander M; Wrange U; Kritikos M; Norrlind B; Svensson M; Bisrat M; Ostelius J
    Drug Dev Ind Pharm; 2006 Feb; 32(2):185-96. PubMed ID: 16537199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Continuous and Reversible Transformation of the Polymorphs of an MGAT2 Inhibitor (S-309309) from the Anhydrate to the Hydrate in Response to Relative Humidity.
    Miyano T; Sugita K; Ueda H
    Pharmaceutics; 2024 Jul; 16(7):. PubMed ID: 39065646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing pseudopolymorphic transitions in pharmaceutical solids using Raman spectroscopy: hydration and dehydration of theophylline.
    Amado AM; Nolasco MM; Ribeiro-Claro PJ
    J Pharm Sci; 2007 May; 96(5):1366-79. PubMed ID: 17455358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Navigating the Waters of Unconventional Crystalline Hydrates.
    Braun DE; Koztecki LH; McMahon JA; Price SL; Reutzel-Edens SM
    Mol Pharm; 2015 Aug; 12(8):3069-88. PubMed ID: 26075319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Integrated View of the Influence of Temperature, Pressure, and Humidity on the Stability of Trimorphic Cysteamine Hydrochloride.
    Gana I; Barrio M; Ghaddar C; Nicolaï B; Do B; Tamarit JL; Safta F; Rietveld IB
    Mol Pharm; 2015 Jul; 12(7):2276-88. PubMed ID: 26042338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The polymorph landscape of dabigatran etexilate mesylate: Taking the challenge to bring a metastable polymorph to market.
    Sieger P; Werthmann U; Saouane S
    Eur J Pharm Sci; 2023 Jul; 186():106447. PubMed ID: 37044200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RH-temperature stability diagram of α- and β-anhydrous and monohydrate lactose crystalline forms.
    Allan MC; Grush E; Mauer LJ
    Food Res Int; 2020 Jan; 127():108717. PubMed ID: 31882085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Compaction Force on the Transition to Hydrate of Anhydrous Aripiprazole.
    Togo T; Taniguchi T; Nakata Y
    Chem Pharm Bull (Tokyo); 2018; 66(3):263-269. PubMed ID: 29491260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphs and hydrates of acyclovir.
    Lutker KM; Quiñones R; Xu J; Ramamoorthy A; Matzger AJ
    J Pharm Sci; 2011 Mar; 100(3):949-63. PubMed ID: 21280051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding.
    Karki S; Friscić T; Jones W; Motherwell WD
    Mol Pharm; 2007; 4(3):347-54. PubMed ID: 17497885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the phase transitions occurring during and after the dehydration of xylazine hydrochloride monohydrate.
    Krūkle-Bērziņa K; Actiņš A
    Int J Pharm; 2014 Jul; 469(1):40-9. PubMed ID: 24732032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.
    Kamada K; Yoshimura S; Murata M; Murata H; Nagai H; Ushio H; Terada K
    Int J Pharm; 2009 Feb; 368(1-2):103-8. PubMed ID: 19007870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal forms of LY334370 HCl: isolation, solid-state characterization, and physicochemical properties.
    Reutzel-Edens SM; Kleemann RL; Lewellen PL; Borghese AL; Antoine LJ
    J Pharm Sci; 2003 Jun; 92(6):1196-205. PubMed ID: 12761809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of hydrate forms of paroxetine HCl from the amorphous state: an evaluation of thermodynamic and experimental predictive approaches.
    Pina MF; Pinto JF; Sousa JJ; Craig DQ; Zhao M
    Int J Pharm; 2015 Mar; 481(1-2):114-24. PubMed ID: 25592956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rapid approach to the preliminary assessment of the physical stability of pharmaceutical hydrates.
    Shimanovich R; Cooke M; Peterson ML
    J Pharm Sci; 2012 Oct; 101(10):4013-7. PubMed ID: 22777723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of four crystal polymorphs and a monohydrate of s-bupivacaine hydrochloride (levobupivacaine hydrochloride).
    Niederwanger V; Gozzo F; Griesser UJ
    J Pharm Sci; 2009 Mar; 98(3):1064-74. PubMed ID: 18729201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transformation pathways of cocrystal hydrates when coformer modulates water activity.
    Jayasankar A; Roy L; Rodríguez-Hornedo N
    J Pharm Sci; 2010 Sep; 99(9):3977-85. PubMed ID: 20623694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varenicline L-tartrate crystal forms: characterization through crystallography, spectroscopy, and thermodynamics.
    Murphy BJ; Huang J; Casteel MJ; Cobani A; Krzyzaniak JF
    J Pharm Sci; 2010 Jun; 99(6):2766-76. PubMed ID: 20091823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.